Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |